Applied twice a week (every 3 to 4 days), CACIPLIQ20® is a unique product which provides an easy-to-use, effective tissue regenerating solution for rapid wound healing. In addition, CACIPLIQ20®, through the healing and restoration of the extracellular matrix, reduces lesion induced pain. CACIPLIQ20® belongs to the family of ReGeneraTing Agents (RGTA®), which are engineered biodegradable sugar based polymers. CACIPLIQ20® is a sterile wound healing solution. it is a class III CE marked Medical Device. CACIPLIQ20® protects extracellular matrix proteins from the inside, hence restoring the matrix architecture. It preserves the natural cellular micro-environment of the wound and the endogenous factors needed for tissue regeneration.
Indications
Chronic ulcers showing no tendency to heal after 6 months of standard care, or still unhealed after 12 months:
- Pressure ulcers.
- Peripheral arterial disease (such as – Stage IV Leriche & Fontaine) ulcers.
- Diabetic ulcers (including amputation).
Improves patient comfort
- Reducing lesion induced pain
- Reducing care time
- Excellent safety record
- Simple to use
Clinical Cases for CACIPLIQ20®
Lorem ipsum dolor sit amet, consectetur adipisicing elit sed do eiusmod tempor incididunt ut labore et dolore magna aliqua enim ad minim. Veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat duis aute irure dolor in reprehenderit.
Lorem ipsum dolor sit amet, consectetur adipisicing elit sed do eiusmod tempor incididunt ut labore et dolore magna aliqua enim ad minim. Veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat duis aute irure dolor in reprehenderit.
